Details for New Drug Application (NDA): 050592

✉ Email this page to a colleague

NDA 050592 describes TOBRADEX, which is a drug marketed by Novartis, Sandoz, and Harrow Eye, and is included in three NDAs. It is available from six suppliers. There are three patents protecting this drug. Additional details are available on the TOBRADEX profile page.

The generic ingredient in TOBRADEX is dexamethasone; tobramycin. There are thirty-nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dexamethasone; tobramycin profile page.

Summary for 050592

Tradename:	TOBRADEX
Applicant:	Sandoz
Ingredient:	dexamethasone; tobramycin
Patents:	0

Suppliers and Packaging for NDA: 050592

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TOBRADEX	dexamethasone; tobramycin	SUSPENSION/DROPS;OPHTHALMIC	050592	NDA AUTHORIZED GENERIC	A-S Medication Solutions	50090-1135	50090-1135-0	2.5 mL in 1 BOTTLE (50090-1135-0)
TOBRADEX	dexamethasone; tobramycin	SUSPENSION/DROPS;OPHTHALMIC	050592	NDA AUTHORIZED GENERIC	A-S Medication Solutions	50090-1136	50090-1136-0	5 mL in 1 BOTTLE (50090-1136-0)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SUSPENSION/DROPS;OPHTHALMIC			Strength	0.1%;0.3%
Approval Date:	Aug 18, 1988	TE:	AB	RLD:	Yes

Expired US Patents for NDA 050592

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sandoz	TOBRADEX	dexamethasone; tobramycin	SUSPENSION/DROPS;OPHTHALMIC	050592-001	Aug 18, 1988	5,149,694	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.